Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
破解密碼：理解分析師對Caribou Biosciences的評論
During the last three months, 5 analysts shared their evaluations of Caribou Biosciences (NASDAQ:CRBU), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，5位分析師分享了他們對Caribou Biosciences（納斯達克: CRBU）的評價，展示了從看漲到看跌的不同觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.0, a high estimate of $24.00, and a low estimate of $9.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.64%.
分析師評估的12個月價格目標揭示了更多信息，其中平均目標爲19.0美元，最高估值爲24.00美元，最低估值爲9.00美元。隨着分析師將平均價格目標下調13.64％，情緒出現了負面變化。
Analyzing Analyst Ratings: A Detailed Breakdown...
分析分析師評...
登入免費觀看全文
登入/註冊